<DOC>
	<DOCNO>NCT02867098</DOCNO>
	<brief_summary>An open label comparison concentration study medication administer intravenously ( IV ) versus subcutaneously ( SC ) healthy volunteer .</brief_summary>
	<brief_title>XmAb5871 Bioavailability Study</brief_title>
	<detailed_description>The study enroll approximately 50 eligible healthy male female subject age 18 55 inclusive . There 5 parallel dose cohort ( Cohorts 1-5 ) consist 10 subject cohort . No subject member 1 cohort . Each subject randomize 1 5 dose cohort . Randomization generate population prior study start . Subjects receive 3 administration study medication .</detailed_description>
	<criteria>Are adult male female age 18 55 year inclusive dosing ( Day 1 ) total body weight 45.0 100.0 kg inclusive body mass index ( BMI ) 19.0 32.0 kg/m2 inclusive ; Healthy assess Investigator clinically significant abnormality identify medical laboratory evaluation history clinically significant disorder , condition , disease would pose risk subject safety interfere study evaluation , procedure , completion ; Subjects clinically relevant history presence respiratory , gastrointestinal , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , connective tissue diseases disorder would pose risk subject safety interfere study evaluation , procedure , completion . Subjects positive drug abuse alcohol screen admission ; Subject pregnant breast feeding , plan become pregnant within 3 month administration XmAb5871 . Subjects use prescription drug ( exception hormonal birth control woman childbearing potential ) within 14 day 5 halflives , whichever longer , prior dose ( Day 1 ) , unless agree clinically relevant Principal Investigator Sponsor . Subjects receive live vaccine â‰¤3 month Day 1 . Malignancy within 5 year ( except successfully treat situ cervical cancer , resect squamous cell basal cell carcinoma skin ) . Unable unwilling partake followup assessment require protocol procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>healthy</keyword>
	<keyword>volunteer</keyword>
</DOC>